跳至主要内容
临床试验/NCT03968328
NCT03968328已完成不适用

The Prognostic Value of the Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 315 人开始时间: 2015年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
315
试验地点
1
主要终点
14 day cause specific mortality rate

研究概览

简要总结

This trial uses an interview and a survey to gather information from cancer patients about the onset of their fever and the administration of antibiotics. Collecting information from patients may help doctors to assess the relationship between time to antibiotic administration and inhospital cause specific death, intensive care unit admission, hospital length of stay, and positive blood cultures.

详细描述

PRIMARY OBJECTIVES:

I. To assess the prognostic value of the length of time between the time onset of fever and first antibiotic administration on cause specific 14 day mortality rate.

SECONDARY OBJECTIVES:

I. To assess the associations of the length of time between the time onset of fever and first antibiotic administration with intensive care unit (ICU) admission, ICU length of stay, length of hospitalization and percentage of patients with positive blood cultures.

OUTLINE:

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

14 day cause specific mortality rate

时间窗: At 14 days

Will perform univariate logistic regression analysis to assess the effect of time to antibiotic administration on death 14 days post fever onset. Will build multivariate logistic regression model(s) to further assess the effect of time to antibiotic administration on death 14 days post fever onset adjusting for other potential confounders.

次要结局

  • ICU length of stay(Up to 5 years)
  • Cause specific death(Up to 5 years)
  • Intensive care unit (ICU) admission rate(Up to 5 years)
  • Length of hospitalization(Up to 5 years)
  • Percentage of patients with positive blood cultures(Up to 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验